Hiromichi Ito - Concepedia

Author

Hiromichi Ito

Japanese Foundation For Cancer Research ORCID

Also Known As

H Ito, H. ITO, H. Ito, HIROMICHI ITO, Hiromichi ITO, Hiromichi Ito, Hisao ITO, Ito Hiromichi, Yu Takahashi

463

Publications

8.4K

Citations

H-Index

146

Concepts

All Affiliations

Japanese Foundation For Cancer Research Brigham and Women's Hospital Harvard University Tokushima University Juntendo University

About

Hiromichi Ito is an author at Japanese Foundation For Cancer Research specializing in medicine, surgery, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	80	4.1K
2	Health Sciences	5	5	237
3	Engineering	4	4	329
4	Education	2	2	66
5	Natural Sciences	2	2	246

Hiromichi Ito

135

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution Michael G. House, Hiromichi Ito, Mithat Gönen, Journal of the American College of Surgeons	2010	513
Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways Talat Waseem, Mark Duxbury, Hiromichi Ito, Surgery InflammationCytokineAnti-inflammatorySignal TransductionAutoimmune Disease	2008	240
RETRACTED ARTICLE: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine Mark Duxbury, Hiromichi Ito, Michael J. Zinner, Oncogene Tumor BiologyPancreatic CancerRna InterferenceNatural SciencesRna Biology	2003	225
Effect of Postoperative Morbidity on Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer Hiromichi Ito, Chandrakanth Are, Mithat Gönen, Annals of Surgery	2008	218
RETRACTED ARTICLE: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma Mark Duxbury, Hiromichi Ito, Michael J. Zinner, Oncogene Potential Therapeutic TargetOncologyPancreatic CancerMalignant DiseaseMedicine	2004	211
Accurate Staging for Gallbladder Cancer Hiromichi Ito, Kaori Ito, Michael I. D’Angelica, Annals of Surgery	2011	207
Inhibition of Src Tyrosine Kinase Impairs Inherent and Acquired Gemcitabine Resistance in Human Pancreatic Adenocarcinoma Cells Mark Duxbury, Hiromichi Ito, Michael J. Zinner, Clinical Cancer Research	2004	192
RETRACTED ARTICLE: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells Mark Duxbury, Hiromichi Ito, Michael J. Zinner, Oncogene Tumor BiologyPancreatic CancerMedicinePathologyRetracted Article	2004	189
Applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy Muga Terasawa, Takeaki Ishizawa, Yoshihiro Mise, Surgical Endoscopy EngineeringOncologic ImagingBiomedical ImagingSurgeryBiophotonics	2017	174
Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness Mark Duxbury, Talat Waseem, Hiromichi Ito, Biochemical and Biophysical Research Communications Pancreatic CancerCellular ProliferationPathologyCellular BiochemistryMedicine	2003	162

Page 1